TY - JOUR
T1 - Nucleotide oligomerization binding domain-like receptor signaling enhances dendritic cell-mediated cross-priming in vivo
AU - Asano, Jumpei
AU - Tada, Hiroyuki
AU - Onai, Nobuyuki
AU - Sato, Taku
AU - Horie, Yasuo
AU - Fujimoto, Yukari
AU - Fukase, Koichi
AU - Suzuki, Akira
AU - Mak, Tak W.
AU - Ohteki, Toshiaki
N1 - Copyright:
Copyright 2010 Elsevier B.V., All rights reserved.
PY - 2010/1/15
Y1 - 2010/1/15
N2 - Nucleotide oligomerization binding domain (Nod)-like receptors are critical cytosolic sensors for the recognition of bacterial peptidoglycan. However, their role in the induction of dendritic cell (DC)-mediated cross-priming remains unclear. In this study, we demonstrate that injecting ligands for Nod1 and Nod2 along with Ag into wild-type mice significantly enhanced the cross-priming of Agspecific CD8+ T cells by CD8α+ DCs, as assessed from the expansion of IFN-γ+ CD8+ T cells, CTL activity against Ag-pulsed targets, and the rejection of transplanted tumors expressing the cognate Ag. The enhancement of CD8α+ DC-mediated cross-priming was likely due to the upregulation of Ag cross-presentation and of costimulatory molecules. Our findings collectively indicate that Nod1/2 signaling is critical for the optimal induction of DC cross-priming in vivo, which may offer an alternative therapeutic pathway in cancer and hosts refractory to TLR signals or paralyzed by viral evasion strategy.
AB - Nucleotide oligomerization binding domain (Nod)-like receptors are critical cytosolic sensors for the recognition of bacterial peptidoglycan. However, their role in the induction of dendritic cell (DC)-mediated cross-priming remains unclear. In this study, we demonstrate that injecting ligands for Nod1 and Nod2 along with Ag into wild-type mice significantly enhanced the cross-priming of Agspecific CD8+ T cells by CD8α+ DCs, as assessed from the expansion of IFN-γ+ CD8+ T cells, CTL activity against Ag-pulsed targets, and the rejection of transplanted tumors expressing the cognate Ag. The enhancement of CD8α+ DC-mediated cross-priming was likely due to the upregulation of Ag cross-presentation and of costimulatory molecules. Our findings collectively indicate that Nod1/2 signaling is critical for the optimal induction of DC cross-priming in vivo, which may offer an alternative therapeutic pathway in cancer and hosts refractory to TLR signals or paralyzed by viral evasion strategy.
UR - http://www.scopus.com/inward/record.url?scp=76249085207&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=76249085207&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.0900726
DO - 10.4049/jimmunol.0900726
M3 - Article
C2 - 20008287
AN - SCOPUS:76249085207
SN - 0022-1767
VL - 184
SP - 736
EP - 745
JO - Journal of Immunology
JF - Journal of Immunology
IS - 2
ER -